IQVIA Settles Allegations of Substandard 401(k) Investments

Healthcare technology giant IQVIA has agreed to a settlement over claims that it mismanaged its $1.13 billion 401(k) plan, as reported in a recent filing with a North Carolina federal court. This agreement resolves a contentious dispute brought by a class of 9,000 participants alleging that IQVIA chose inferior, high-cost investments for its retirement plan.

Details of the Settlement

The specifics of the settlement, reached between IQVIA and four former employees, remain under wraps. However, both parties have informed the court of their decision to conclude their Employee Retirement Income Security Act (ERISA) disagreement. A motion for preliminary approval of the settlement is expected by May 15, well ahead of a bench trial initially scheduled for September.

IQVIA's Defense and Plaintiffs' Claims

In defense, IQVIA contended that the expert analysis provided by the plaintiffs inappropriately compared their plan's performance with only the most successful funds, an approach the company criticized as selective and not reflective of typical fiduciary decisions. Conversely, the plaintiffs maintained that their expert's comparison was robust, illustrating what a well-performing fund would entail, thereby demonstrating the inadequacies of their own plan's funds.

IQVIA 401(k) Suit: Legal Proceedings and Allegations

The lawsuit, initiated in June 2020 by the company’s former employees, accused IQVIA and its leadership of failing to adhere to federal benefits law by endorsing poor-quality investments that were pricier than those available to similar plans. The plaintiffs argued that IQVIA could have saved approximately $4.5 million in 2018 alone by opting for less expensive, less risky index funds over the selected active funds.

IQVIA 401(k) Suit: Fiduciary Duties and Summary Judgments

While U.S. District Judge William L. Osteen Jr. agreed to send certain claims to trial, he ruled in favor of IQVIA on allegations of disloyalty towards plan participants. The trial will examine whether the decision-makers violated their fiduciary duty of prudence by choosing such investments.

IQVIA 401(k) Suit: The Larger Impact and IQVIA's Role

The class action encapsulates all individuals involved in the plan from mid-2014 through the case's conclusion. IQVIA, headquartered in Durham, North Carolina, is renowned for its clinical research efforts to develop new pharmaceutical treatments.

Representatives from both sides, including those from prominent law firms such as Goodwin Procter LLP and Miller Shah LLP, have not yet commented on the settlement.